Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 9, 2023
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
Charles Duncan Reiterated (AXSM) at Buy and Held Target at $104 on, May 9th, 2023
Charles Duncan of Cantor Fitzgerald, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Buy and Held Target at $104 on, May 9th, 2023.
Charles has made no other calls on AXSM in the last 4 months.
There are 3 other peers that have a rating on AXSM. Out of the 3 peers that are also analyzing AXSM, 0 agree with Charles's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Charles
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $200 on, Monday, April 17th, 2023
- Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $84 on, Monday, March 13th, 2023
- Jason Gerberry of "B of A Securities" Reiterated at Sell and Held Target at $52 on, Tuesday, February 14th, 2023
